JOHANNESBURG - The first drug shown to prevent HIV infection won the endorsement of a panel of US Federal advisors on Friday.
This clears the way for a landmark approval in the fight against the virus that causes AIDS.
In a series of votes held in America, the Food and Drug Administration advisory panel recommended the approval of the daily drug, Truvada, for people who are at high risk of contracting HIV.
Wits University Professor Ian Sanne said this is a breakthrough in HIV treatment.
“It is very exciting for those who are at risk for acquiring HIV. This will transpire for use internationally.”
(Edited by Zethu Zulu)